Immunization with “naked” nanoparticles lacking malaria epitopes (CSP-negative nanoparticles) conferred nonsignificant levels of reduction in liver burden in this assay (Fig. 4g), suggesting that the base nanoparticle itself made minimal contributions to liver burden reduction for nanoparticles displaying CSP epitopes. Here, DNAJC5 is linked to malaria.